Purdue Pharma, the opioid drug-maker owned by the billionaire Sackler family, is reported to be offering between $10bn and $12bn to settle thousands of lawsuits against it.
The firm is facing over 2,000 lawsuits linked to its painkiller OxyContin.
Purdue told the BBC it was “actively working” towards a “global resolution” but would not comment on the amount.
NBC, which first reported the news, said the settlement would involve the Sacklers giving up ownership of Purdue.
The firm said in a statement: “While Purdue Pharma is prepared to defend itself vigorously in the opioid litigation, the company has made clear that it sees little good coming from years of wasteful litigation and appeals.
“Purdue believes a constructive global resolution is the best path forward, and the company is actively working with the state attorneys general and other plaintiffs to achieve this outcome.”
